2024-03-28 05:50:00 ET
What's the hottest biotech stock on the market right now? If we limit the list only to those with market caps of at least $500 million, it's Viking Therapeutics (NASDAQ: VKTX) . So far in 2024, Viking's shares have skyrocketed over 270% (and were up even higher at points).
Is it too late for investors to jump aboard the Viking bandwagon? I don't think so. Here are five things you need to know if you buy Viking Therapeutics stock today.
Viking's impressive year-to-date stock performance is due to excitement about the prospects of its experimental drug VK2735. In February, the company reported overwhelmingly positive top-line results from the phase 2 Venture clinical trial evaluating the dual GLP-1/GIP receptor agonist in patients with obesity.
For further details see:
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today